Of Mice and Men: Comparative Analysis of Neuro-Inflammatory Mechanisms in Human and Mouse Using Cause-and-Effect Models

Perturbance in inflammatory pathways have been identified as one of the major factors which leads to neurodegenerative diseases (NDD). Owing to the limited access of human brain tissues and the immense complexity of the brain, animal models, specifically mouse models, play a key role in advancing the NDD field. However, many of these mouse models fail to reproduce the clinical manifestations and end points of the disease. NDD drugs, which passed the efficacy test in mice, were repeatedly not successful in clinical trials. There are numerous studies which are supporting and opposing the applicability of mouse models in neuroinflammation and NDD. In this paper, we assessed to what extend a mouse can mimic the cellular and molecular interactions in humans at a mechanism level. Based on our mechanistic modeling approach, we investigate the failure of a neuroinflammation targeted drug in the late phases of clinical trials based on the comparative analyses between the two species.

[1]  D. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[2]  Alessandro Lombardo,et al.  A computational model to predict the immune system activation by citrus-derived vaccine adjuvants , 2016, Bioinform..

[3]  A. Caccamo,et al.  Pim1 inhibition as a novel therapeutic strategy for Alzheimer’s disease , 2016, Molecular Neurodegeneration.

[4]  Martin Hofmann-Apitius,et al.  Computable cause-and-effect models of healthy and Alzheimer's disease states and their mechanistic differential analysis , 2015, Alzheimer's & Dementia.

[5]  Sterling C. Johnson,et al.  Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease. , 2015, JAMA neurology.

[6]  Burkhard Becher,et al.  Immune attack: the role of inflammation in Alzheimer disease , 2015, Nature Reviews Neuroscience.

[7]  R. Sankowski,et al.  Rodent models of neuroinflammation for Alzheimer’s disease , 2015, Journal of Neuroinflammation.

[8]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[9]  Keizo Takao,et al.  Genomic responses in mouse models greatly mimic human inflammatory diseases , 2014, Proceedings of the National Academy of Sciences.

[10]  Michael T. Heneka,et al.  Innate immune activation in neurodegenerative disease , 2014, Nature Reviews Immunology.

[11]  S. Pimplikar Neuroinflammation in Alzheimer’s Disease: from Pathogenesis to a Therapeutic Target , 2014, Journal of Clinical Immunology.

[12]  Allan R. Jones,et al.  Transcriptional Landscape of the Prenatal Human Brain , 2014, Nature.

[13]  M. Sastre,et al.  Modulation of inflammation in transgenic models of Alzheimer’s disease , 2014, Journal of Neuroinflammation.

[14]  R. Burke,et al.  Rheb GTPase Regulates β-Secretase Levels and Amyloid β Generation* , 2013, The Journal of Biological Chemistry.

[15]  M. Hofmann-Apitius,et al.  From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine , 2013, EPMA Journal.

[16]  Xiaoyuan Chen,et al.  Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics , 2013, Pharmacological Reviews.

[17]  Daniel R. Richards,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013, Proceedings of the National Academy of Sciences.

[18]  Shaohui Wang,et al.  Tuberous sclerosis protein 2 (TSC2) modulates CCN4 cytoprotection during apoptotic amyloid toxicity in microglia. , 2012, Current neurovascular research.

[19]  G. Ferraccioli,et al.  Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation. , 2012, Discovery medicine.

[20]  T. Noda,et al.  Loss of Pdk1-Foxo1 Signaling in Myeloid Cells Predisposes to Adipose Tissue Inflammation and Insulin Resistance , 2012, Diabetes.

[21]  W. Klein,et al.  Intracellular Aβ-oligomers and early inflammation in a model of Alzheimer's disease , 2012, Neurobiology of Aging.

[22]  R. Glazer,et al.  PPARδ Activation Acts Cooperatively with 3-Phosphoinositide-Dependent Protein Kinase-1 to Enhance Mammary Tumorigenesis , 2011, PloS one.

[23]  P. Hart,et al.  The anti‐inflammatory effects of interleukin‐4 are not mediated by suppressor of cytokine signalling‐1 (SOCS1) , 2010, Immunology.

[24]  D. Howells,et al.  Can Animal Models of Disease Reliably Inform Human Studies? , 2010, PLoS medicine.

[25]  D. Baker,et al.  Inflammation in neurodegenerative diseases , 2010, Immunology.

[26]  B. Culver,et al.  Suppression of nuclear factor kappa B ameliorates astrogliosis but not amyloid burden in APPswe/PS1dE9 mice , 2009, Neuroscience.

[27]  E. Masliah,et al.  Role of Tuberin in Neuronal Degeneration , 2008, Neurochemical Research.

[28]  J. Strosznajder,et al.  Inhibitor of cyclooxygenase-2 protects against amyloid beta peptide-evoked memory impairment in mice. , 2007, Pharmacological reports : PR.

[29]  B. Aggarwal,et al.  Cyclooxygenase (COX)-2 Inhibitor Celecoxib Abrogates TNF-Induced NF-κB Activation through Inhibition of Activation of IκBα Kinase and Akt in Human Non-Small Cell Lung Carcinoma: Correlation with Suppression of COX-2 Synthesis1 , 2004, The Journal of Immunology.

[30]  D. V. van Aalten,et al.  PDK1, the master regulator of AGC kinase signal transduction. , 2004, Seminars in cell & developmental biology.

[31]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.

[32]  Y. Song,et al.  Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. , 2003, Carcinogenesis.

[33]  D. Westaway,et al.  Transgenic mouse models of Alzheimer's disease , 2001, Physiology & Behavior.

[34]  P. Cohen,et al.  The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells , 2000, Current Biology.

[35]  B. Hyman,et al.  APPSW Transgenic Mice Develop Age‐related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1 , 1997, Journal of neuropathology and experimental neurology.

[36]  N. Goldstein Mice are not men! , 1994, Hawaii medical journal.

[37]  L. Kurland,et al.  Rheumatoid arthritis and susceptibility to Alzheimer's disease , 1991, The Lancet.

[38]  D. Scott,et al.  Rheumatold Arthritis and Senile Dementia of the Alzhelmer's Type , 1989 .

[39]  P. Treuting,et al.  Comprar Comparative Anatomy And Histology. A Mouse And Human Atlas (Online And Print) | Piper M. Treuting | 9780123813619 | Academic Press , 2011 .

[40]  Huidong Tang,et al.  PPARgamma agonist curcumin reduces the amyloid-beta-stimulated inflammatory responses in primary astrocytes. , 2010, Journal of Alzheimer's disease : JAD.